Here are six key trends:
1. The market is estimated to be valued at $3.7 billion by the end of 2015.
2. It is expected to grow at a compound annual growth rate of 11.2 percent.
3. By 2022, the market is expected to reach a value of $7.7 billion.
4. The growing geriatric population, rising incidence of brain tumors and increase in government funding are all contributing to the market’s growth.
5. The North America market is growing at a significant rate due to increasing healthcare expenditure and increasing the prevalence of brain tumor in the region.
6. Integra LifeSciences, KARL STORZ, Medtronic, Stryker and Elekta are some of the major players in the neurosurgical products market.
More articles on devices:
Aurora Spine, LDR, SeaSpine & more — 12 key notes
5 things to know about MicroPort Orthopedics’ Profemur Preserve Hip Stem
FTC final order preserves competition: 5 things to know about Zimmer’s acquisition of Biomet
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
